Purchase this article with an account.
Alejandro Tamez, Jesus Lozano, Manuel De Alba, Julio C Hernandez, Jorge E Valdez; Micro-Monovision LASIK as a treatment for presbyopia. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3941.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To investigate the efficacy and safety of LASIK monovision technique as a treatment for ametropia and presbyopia.
A retrospective case series study that included 70 eyes of 35 ametropic and presbyobic patients that were treated with LASIK monovision in our Cornea and Refractive surgery service from January 2013 to February 2014. We evaluated the postoperative uncorrected binocular visual acuity: for distance and near. The target refraction was emetropia for the dominant eye and between -1.00 to -2.00 in the non-dominant eye. All surgeries where operated by the same two refractive surgeons, with the same equipment, technique and surgery conditions.
The average patient age was 50.9 years old (39-64), of which 60% were women. Refractive error: 26 with hyperopic astigmatism, 4 with simple hyperopia and 5 with myopic astigmatism. The Binocular distance visual acuity was 20/25 or better in 94% of patients and binocular near vision was J2 or better in 97% of patients. Mean follow-up of 4.4 months (1-12).
LASIK Micro-Monovision technique has proven to be a well-tolerated, safe and effective way to treat ametropia and presbyopia.
This PDF is available to Subscribers Only